643 related articles for article (PubMed ID: 30170220)
1. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
[TBL] [Abstract][Full Text] [Related]
3. Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis.
Fadaei R; Poustchi H; Meshkani R; Moradi N; Golmohammadi T; Merat S
Sci Rep; 2018 Aug; 8(1):11691. PubMed ID: 30076407
[TBL] [Abstract][Full Text] [Related]
4. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
5. Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol.
van den Berg EH; Gruppen EG; James RW; Bakker SJL; Dullaart RPF
J Lipid Res; 2019 Jan; 60(1):168-175. PubMed ID: 30455362
[TBL] [Abstract][Full Text] [Related]
6. Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease.
Nass KJ; van den Berg EH; Gruppen EG; Dullaart RPF
Eur J Clin Invest; 2018 Sep; 48(9):e12988. PubMed ID: 29947103
[TBL] [Abstract][Full Text] [Related]
7. Relationship between Oxidative Stress, Inflammation and Dyslipidemia with Fatty Liver Index in Patients with Type 2 Diabetes Mellitus.
Klisic A; Isakovic A; Kocic G; Kavaric N; Jovanovic M; Zvrko E; Skerovic V; Ninic A
Exp Clin Endocrinol Diabetes; 2018 Jun; 126(6):371-378. PubMed ID: 28895641
[TBL] [Abstract][Full Text] [Related]
8. Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study.
Annema W; Dikkers A; de Boer JF; van Greevenbroek MMJ; van der Kallen CJH; Schalkwijk CG; Stehouwer CDA; Dullaart RPF; Tietge UJF
Sci Rep; 2016 Jun; 6():27367. PubMed ID: 27270665
[TBL] [Abstract][Full Text] [Related]
9. The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male.
Mansyur MA; Bakri S; Patellongi IJ; Rahman IA
Clin Nutr ESPEN; 2020 Feb; 35():69-74. PubMed ID: 31987123
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
[TBL] [Abstract][Full Text] [Related]
11. Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids.
van den Berg EH; Flores-Guerrero JL; Gruppen EG; de Borst MH; Wolak-Dinsmore J; Connelly MA; Bakker SJL; Dullaart RPF
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917546
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.
Nass KJ; van den Berg EH; Faber KN; Schreuder TCMA; Blokzijl H; Dullaart RPF
Metabolism; 2017 Jul; 72():37-46. PubMed ID: 28641782
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
[TBL] [Abstract][Full Text] [Related]
14. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents.
Pacifico L; Bonci E; Andreoli G; Romaggioli S; Di Miscio R; Lombardo CV; Chiesa C
Nutr Metab Cardiovasc Dis; 2014 Jul; 24(7):737-43. PubMed ID: 24656140
[TBL] [Abstract][Full Text] [Related]
15. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).
Akinmolayemi O; Saldanha S; Joshi PH; Deodhar S; Ayers CR; Neeland IJ; Rohatgi A
PLoS One; 2021; 16(9):e0257574. PubMed ID: 34547056
[TBL] [Abstract][Full Text] [Related]
17. Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.
van den Berg EH; van Tienhoven-Wind LJ; Amini M; Schreuder TC; Faber KN; Blokzijl H; Dullaart RP
Metabolism; 2017 Feb; 67():62-71. PubMed ID: 28081779
[TBL] [Abstract][Full Text] [Related]
18. Plasma ApoE elevations are associated with NAFLD: The PREVEND Study.
van den Berg EH; Corsetti JP; Bakker SJL; Dullaart RPF
PLoS One; 2019; 14(8):e0220659. PubMed ID: 31386691
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.
Rivera-Andrade A; Kroker-Lobos MF; Lazo M; Freedman ND; Smith JW; Torres O; McGlynn KA; Groopman JD; Guallar E; Ramirez-Zea M
Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):191-200. PubMed ID: 30573307
[TBL] [Abstract][Full Text] [Related]
20. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
